QA: AbbVie Inc. in us_pharma/2017

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2018_AbbVie_Inc.pdf

Logs

info Added remainder_ComprehensiveNetIncome directly from 10K industry.us_generic {}

Graph

Absolute values for 0001551152, AbbVie Inc.

  xvar xval
0 AssetsCurrent 21,223,000,000
1 IntangibleAssetsNetIncludingGoodwill 43,344,000,000
2 PropertyPlantAndEquipmentNet 2,803,000,000
3 remainder_Assets 3,416,000,000
4 LiabilitiesCurrent 16,641,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 6,275,000,000
9 ResearchAndDevelopmentExpense 5,309,000,000
10 remainder_Expenses 9,458,000,000
11 remainder_Revenues 28,216,000,000
12 remainder_NetIncome -1,865,000,000
13 remainder_ComprehensiveNetIncome -141,000,000
  yvar yval
0 Assets 70,786,000,000
1 Liabilities 16,641,000,000
2 Expenses 21,042,000,000
3 Revenues 28,216,000,000
4 StockholdersEquity 54,145,000,000
5 NetIncome 5,309,000,000
6 ComprehensiveNetIncome 5,238,500,000
7 BaseVar 69,345,500,000
8 EconomicCapitalRatio 2.25

Edgar->Model Mapping

Feature Distribution

Change over Time